Acquiring Company
Gujarat Themis Biosyn Limited
Acquired Company
MicroBiopharm Japan Ltd
Description
Gujarat Themis Biosyn Limited (GTBL) has completed the acquisition of MicroBiopharm Japan for ¥21.5 billion. This strategic move gives GTBL access to advanced technologies and established relationships within the global pharmaceuticals market. The acquisition aligns with GTBL's ambition to transform into a fully integrated global CDMO. With this deal, GTBL aims to enhance its competitiveness in the pharmaceutical landscape.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Gujarat Themis Biosyn Limited makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Trusted by
M&A Insights
Based on deal dataFrequently asked
Who acquired MicroBiopharm Japan Ltd?
MicroBiopharm Japan Ltd was acquired by Gujarat Themis Biosyn Limited, based in Mumbai. The deal was reported on September 18, 2026. Gujarat Themis Biosyn Limited is a leading biopharmaceutical company focused on fermentation-based intermediates and contract development manufacturing. Gujarat Themis Biosyn Limited is privately held and operates in Manufacturing.
When did Gujarat Themis Biosyn Limited acquire MicroBiopharm Japan Ltd?
Gujarat Themis Biosyn Limited's acquisition of MicroBiopharm Japan Ltd was reported on September 18, 2026. Gujarat Themis Biosyn Limited (GTBL) has completed the acquisition of MicroBiopharm Japan for ¥21.5 billion. This strategic move gives GTBL access to advanced technologies and established relationships within the global pharmaceuticals market. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does MicroBiopharm Japan Ltd do?
MicroBiopharm Japan Co., Ltd. (MBJ) is a well-established Japanese company with over sixty years of experience in fermentation and microbial-based R&D. It is privately held, operating in Manufacturing, and is based in Japan.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.
5 screens from a live account. No signup.